Immunic
$1.15
103
+$0.04+3.6% Today
Statistics
Day High
1.21
Day Low
1.13
52W High
1.51
52W Low
0.51
Volume
1,834,547
Avg. Volume
3,529,924
Mkt Cap
138.33M
P/E Ratio
-
Dividend Yield
-
Dividend
-
Upcoming
Earnings
7MayExpected
Expected EPS
-0.084444
Actual EPS
N/A
Financials
-Profit Margin
Unprofitable0Revenue
-201.01MNet Income
Analyst Ratings
$5.33Average Price Target
The highest estimate is 7.00.
From 3 ratings within the last 6 months. This is not an investment recommendation.
From 3 ratings within the last 6 months. This is not an investment recommendation.
Buy 100%
Hold 0%
Sell 0%
People Also Follow
This list is based on the watchlists of people on Stock Events who follow IMUX. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
Biogen
BIIB
Mkt Cap22.63B
Gilead Sciences
GILD
Mkt Cap148.78B
Abbvie
ABBV
Mkt Cap385.18B
AMGEN
AMGN
Mkt Cap160.66B
Bristol-Myers Squibb
BMY
Mkt Cap93.79B
Regeneron Pharmaceuticals
REGN
Mkt Cap68.5B
Vertex Pharmaceuticals
VRTX
Mkt Cap109.11B
Novartis
NVS
Mkt Cap237.61B
Pfizer
PFE
Mkt Cap140.15B
About
Immunic, Inc., a clinical-stage biopharmaceutical company, develops a pipeline of selective oral immunology therapies for the treatment of chronic inflammatory and autoimmune diseases. Its lead development program is IMU-838, which is in Phase 2 clinical for treatment of relapsing-remitting multiple sclerosis, inflammatory bowel disease, and other chronic inflammatory and autoimmune diseases, as well as to treat coronavirus disease. The company is also developing IMU-935, an inverse agonist of ROR?t; and IMU-856 for the restoration of the intestinal barrier function in patients suffering from diseases, such as inflammatory bowel disease, irritable bowel syndrome with diarrhea, immune checkpoint inhibitor induced colitis, and other intestinal barrier function diseases. Immunic, Inc. is headquartered in New York, New York.
Show more...
CEO
Dr. Duane D. Nash J.D., M.B.A., M.D.
Employees
91
Country
US
ISIN
US4525EP1011
Listings
0 Comments
Share your thoughts
FAQ
What is Immunic stock price today?▼
The current price of IMUX is $1.15 USD — it has increased by +3.6% in the past 24 hours. Watch Immunic stock price performance more closely on the chart.
What is Immunic stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Immunic stocks are traded under the ticker IMUX.
Is Immunic stock price growing?▼
IMUX stock has fallen by -12.88% compared to the previous week, the month change is a +12.75% rise, over the last year Immunic has showed a +7.98% increase.
What is Immunic market cap?▼
Today Immunic has the market capitalization of 138.33M
When is the next Immunic earnings date?▼
Immunic is going to release the next earnings report on May 07, 2026.
What were Immunic earnings last quarter?▼
IMUX earnings for the last quarter are -0.1 USD per share, whereas the estimation was -0.09 USD resulting in a -11.11% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Immunic revenue for the last year?▼
Immunic revenue for the last year amounts to 0 USD.
What is Immunic net income for the last year?▼
IMUX net income for the last year is -201.01M USD.
How many employees does Immunic have?▼
As of April 01, 2026, the company has 91 employees.
In which sector is Immunic located?▼
Immunic operates in the Health Care sector.
When did Immunic complete a stock split?▼
The last stock split for Immunic was on April 15, 2019 with a ratio of 1:40.
Where is Immunic headquartered?▼
Immunic is headquartered in New York, US.